by October Gallery
GENEVA (Reuters) – The United Nations named an Emergency Ebola Response Coordinator on Thursday, creating a new position to boost efforts to contain a 10-month epidemic in the Democratic Republic…
(Reuters) – JPMorgan Chase & Co has cut ties with Purdue Pharma LP over the OxyContin maker’s alleged role in the U.S. opioid crisis, forcing it to find a new…
FILE PHOTO: The logo of Swiss drugmaker Novartis AG is seen at its headquarters in Basel, Switzerland January 25, 2017. REUTERS/Arnd Wiegmann BOSTON (Reuters) – Novartis AG’s top executive said…
FILE PHOTO – One-year-old Bella Huang cries as medical assistants secure her legs for a series of vaccines at the International Community Health Services clinic in Seattle, Washington, U.S., March…
WASHINGTON (Reuters) – U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices – sometimes by…
WASHINGTON (Reuters) – U.S. states filed a lawsuit accusing Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other drug companies to inflate drug prices – sometimes by…
(Reuters Health) – Almost three in four U.S. allergy specialists are prescribing tablets to ease symptoms caused by pollen, ragweed and dust at least some of the time, though they…
(Reuters) – Jacobus Pharmaceutical Co Inc on Monday won U.S. approval for the first drug to treat children with Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder. The drug, Ruzurgi, was…
(Reuters Health) – Many patients with neurologic disorders like multiple sclerosis, epilepsy and Parkinson’s disease have seen steep increases in their out-of-pocket costs for drugs in recent years, a U.S.…
CHICAGO (Reuters) – Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries. Amgen’s migraine treatment,…